US researchers investigate gene therapy treatment for X-linked retinitis pigmentosa
Researchers from the University of Pennsylvania have revealed a new animal study data, which analyses the efficacy of an investigational, adeno-associated virus (AAV) vector gene therapy treatment for X-linked retinitis pigmentosa (XLRP).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Adenoviruses | Gene Therapy | Genetics | Pharmaceuticals | Retinitis Pigmentosa | Study | University of Pennsylvania